CSB
MEDIA, JOBS & RESOURCES FOR THE COMMON GOOD
NEWS  |  Corporate Engagement, Good Business

Wesfarmers Donate to Women’s Cancer Research


Tuesday, 25th November 2014 at 3:03 pm
Lina Caneva, Editor
A donation of $5 million from one of Australia's largest listed companies Wesfarmers is set to have a major impact on women’s cancer research in Western Australia.

Tuesday, 25th November 2014
at 3:03 pm
Lina Caneva, Editor


0 Comments


FREE SOCIAL
SECTOR NEWS

 Print
Wesfarmers Donate to Women’s Cancer Research
Tuesday, 25th November 2014 at 3:03 pm

A donation of $5million from one of Australia's largest listed companies Wesfarmers is set to have a major impact on women’s cancer research in Western Australia.

The Chairman of the Harry Perkins Institute of Medical Research, Laurence Iffla, says Wesfarmers has donated $5 million to establish Western Australia’s first Professorial Chair in Women’s Cancers.

Wesfarmers which owns Coles, Target and Kmart was set up the company in 1914 as a Western Australian farmers' cooperative.

“This gift will enable the appointment of an outstanding scientist to lead the new Perkins Centre for Women’s Cancer Research,” Iffla said.

The Director of the Harry Perkins Institute of Medical Research, Professor Peter Leedman, said the centre would focus on defeating two of the most challenging diseases facing women:  breast cancer and ovarian cancer.

“One in eight Australian women will be diagnosed with breast cancer,” Professor Leedman said.

“As a result of medical research, survival rates for women with breast cancer have increased but more work is urgently needed, particularly on “triple negative” breast cancer, the cancer for which there is currently no successful targeted treatment.

“For the thousands of women who suffer from the “silent killer”, ovarian cancer, the future is bleak.  With a survival rate of less than 20 per cent, cancer of the ovary is the most prevalent, and lethal, form of gynaecological cancer.

“Further discovery-based medical research will result in more effective and targeted treatments,” Professor Leedman said.

The Institute will soon advertise for a leading researcher to fill the Wesfarmers Chair in Women’s Cancers position.

The Harry Perkins Institute for Medical Research aims to  improve the health of Western Australians through cutting edge research that translates into new ways to prevent and treat disease. The cancers under study include breast, prostate, melanoma, colon, head and neck, liver and leukaemia.


Lina Caneva  |  Editor  |  @ProBonoNews

Lina Caneva has been a journalist for more than 35 years, and Editor of Pro Bono Australia News since it was founded in 2000.


Got a story to share?

Got a news tip or article idea for Pro Bono News? Or perhaps you would like to write an article and join a growing community of sector leaders sharing their thoughts and analysis with Pro Bono News readers?

Get in touch at news@probonoaustralia.com.au

Get more stories like this

FREE SOCIAL
SECTOR NEWS

YOU MAY ALSO LIKE

Mental Illness a Leading Cause of Disability for Australian Women

Luke Michael

Friday, 9th March 2018 at 12:43 pm

In Conversation With Natasha Stott Despoja AM

Wendy Williams

Tuesday, 27th February 2018 at 8:39 am

Social Media Campaign Looks to End Use Of the Word ‘Retard’

Luke Michael

Monday, 26th February 2018 at 4:38 pm

Governance for Deductible Gift Recipients

Contributor

Tuesday, 12th December 2017 at 8:25 am

POPULAR

Animal Shelter Loses Charity Status

Wendy Williams

Wednesday, 11th April 2018 at 5:20 pm

NFP Real Estate Agency to Drive Sydney’s Affordable Housing Supply

Wendy Williams

Wednesday, 11th April 2018 at 5:34 pm

NDIS Urged to Implement Portable Training System for Workers

Luke Michael

Tuesday, 17th April 2018 at 8:31 am

AMA Calls For “Bipartisan Commitment” to Fund NDIS

Luke Michael

Thursday, 12th April 2018 at 5:22 pm

Write a Reply or Comment

Your email address will not be published. Required fields are marked *


CSB
pba inverse logo
Subscribe Twitter Facebook

Get the social sector's most essential news coverage. Delivered free to your inbox every Tuesday and Thursday morning.

You have Successfully Subscribed!